A Conversation with Kyowa Kirin

Building a Rare Disease Franchise

How ML, AI and RWD Optimizes Commercial and Patient Outcomes

Featuring Richard Wilson, Vice President, Rare Disease Franchise Head, Kyowa Kirin, and Nitin Choudhary, Managing Principal, IPM.ai, this webcast showcases how rare disease franchises can successfully utilize privacy safe Real World Data to increase sales velocity, improve patient lifetime value and accelerate time to peak revenue. Hear how IPM.ai partnered with Kyowa Kirin to implement ML/AI-based patient finding for its X-linked hypophosphatemia (XLH) therapy to uncover undiagnosed patients, better understand the patient treatment journey and create highly accurate field intelligence for salesforce optimization. Also, learn how Kyowa Kirin scaled the technology into its oncology division to support its cutaneous T-cell lymphoma (CTCL) therapy. IPM.ai and Kyowa Kirin share best practices for rare disease businesses seeking to implement ML/AI for optimized commercial and patient outcomes.

Watch the Replay Read the Q&A

Richard Wilson
VP, Rare Disease Franchise Head




Managing Principal



Want to Know More?

Learn how IPM.ai transforms real world data into real world insights that uncover the ideal patient and their healthcare ecosystem so pharmaceutical companies can accelerate the successful research, development and commercialization of life-savings therapies.